Home Biosimilar Antibodies Immunology & Inflammation PD-1/PD-L1 antibody Retifanlimab (Anti-PDCD1 / PD-1 / CD279) For research use only.
Not for use in humans.

Retifanlimab (Anti-PDCD1 / PD-1 / CD279)

Synonyms: INCMGA 0012

Retifanlimab (Anti-PDCD1 / PD-1 / CD279) is a monoclonal antibody targeting programmed cell death protein 1 (anti-PD-1). It can be used for the research of gastroesophageal adenocarcinoma (GEA). MW :145.64 KD.

Retifanlimab (Anti-PDCD1 / PD-1 / CD279)

Purity & Quality Control

Batch: A303701 Purity: 99% Protein concentration: 6.86mg/ml Endotoxin Level: ＜1EU/mg
99

Choose Selective PD-1/PD-L1 Inhibitors

Biological Activity

Description Retifanlimab (Anti-PDCD1 / PD-1 / CD279) is a monoclonal antibody targeting programmed cell death protein 1 (anti-PD-1). It can be used for the research of gastroesophageal adenocarcinoma (GEA). MW :145.64 KD.

Product Details

CAS No. 2079108-44-2
Isotype Human IgG4SP
Source CHO
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Retifanlimab (Anti-PDCD1 / PD-1 / CD279) | Retifanlimab (Anti-PDCD1 / PD-1 / CD279) supplier | purchase Retifanlimab (Anti-PDCD1 / PD-1 / CD279) | Retifanlimab (Anti-PDCD1 / PD-1 / CD279) cost | Retifanlimab (Anti-PDCD1 / PD-1 / CD279) manufacturer | order Retifanlimab (Anti-PDCD1 / PD-1 / CD279) | Retifanlimab (Anti-PDCD1 / PD-1 / CD279) distributor